Latest Insider Transactions at Sarepta Therapeutics, Inc. (SRPT)
This section provides a real-time view of insider transactions for Sarepta Therapeutics, Inc. (SRPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sarepta Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sarepta Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2024
|
Hans Lennart Rudolf Wigzell |
SELL
Open market or private sale
|
Direct |
10,500
-31.49%
|
$1,302,000
$124.84 P/Share
|
|
Dec 12
2024
|
Hans Lennart Rudolf Wigzell |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+23.95%
|
$136,500
$13.71 P/Share
|
|
Dec 05
2024
|
Kathryn Jean Boor |
SELL
Open market or private sale
|
Direct |
1,636
-21.77%
|
$204,500
$125.55 P/Share
|
|
Nov 26
2024
|
Cristin Rothfuss EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+12.64%
|
-
|
|
Nov 18
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,558
-6.31%
|
$464,916
$102.89 P/Share
|
|
Sep 12
2024
|
Deirdre P Connelly |
BUY
Grant, award, or other acquisition
|
Direct |
2,842
+50.0%
|
-
|
|
Sep 04
2024
|
M Kathleen Behrens |
SELL
Bona fide gift
|
Direct |
746
-0.39%
|
-
|
|
Aug 30
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,985
-14.99%
|
$819,945
$137.36 P/Share
|
|
Aug 16
2024
|
Michael Andrew Chambers |
BUY
Open market or private purchase
|
Indirect |
37,038
+4.3%
|
$4,926,054
$133.93 P/Share
|
|
Jul 03
2024
|
M Kathleen Behrens |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.25%
|
$195,000
$13.9 P/Share
|
|
Jun 25
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Open market or private sale
|
Direct |
3,898
-18.33%
|
$635,374
$163.23 P/Share
|
|
Jun 25
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
38,957
-14.51%
|
$6,272,077
$161.43 P/Share
|
|
Jun 25
2024
|
Ryan Edward Brown EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
23,500
+29.53%
|
$1,457,000
$62.77 P/Share
|
|
Jun 24
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Open market or private sale
|
Direct |
7,859
-5.84%
|
$1,288,876
$164.8 P/Share
|
|
Jun 24
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,352
-7.47%
|
$385,728
$164.64 P/Share
|
|
Jun 24
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,483
-5.85%
|
$407,212
$164.64 P/Share
|
|
Jun 24
2024
|
Dallan Murray Chief Customer Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,352
-9.65%
|
$385,728
$164.64 P/Share
|
|
Jun 24
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,182
-2.94%
|
$357,848
$164.64 P/Share
|
|
Jun 24
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,352
-6.73%
|
$385,728
$164.64 P/Share
|
|
Jun 21
2024
|
Bilal Arif Chief Tech Ops Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+16.57%
|
-
|
|
Jun 21
2024
|
Ian Michael Estepan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+12.84%
|
-
|
|
Jun 21
2024
|
Dallan Murray Chief Customer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+20.41%
|
-
|
|
Jun 21
2024
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+7.76%
|
-
|
|
Jun 21
2024
|
Ryan Edward Brown EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+15.17%
|
-
|
|
May 02
2024
|
Dallan Murray Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
3,635
-16.71%
|
$508,900
$140.0 P/Share
|
|
Mar 11
2024
|
Kathryn Jean Boor |
SELL
Open market or private sale
|
Direct |
761
-9.19%
|
$92,842
$122.93 P/Share
|
|
Mar 08
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-2.78%
|
$127,305
$123.14 P/Share
|
|
Mar 08
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-3.04%
|
$110,577
$123.14 P/Share
|
|
Mar 08
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
909
-1.32%
|
$111,807
$123.14 P/Share
|
|
Mar 08
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-1.84%
|
$58,056
$123.14 P/Share
|
|
Mar 08
2024
|
Hans Lennart Rudolf Wigzell |
SELL
Open market or private sale
|
Direct |
15,000
-14.21%
|
$1,845,000
$123.11 P/Share
|
|
Mar 08
2024
|
Hans Lennart Rudolf Wigzell |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+28.39%
|
$195,000
$13.9 P/Share
|
|
Mar 07
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
526
-1.39%
|
$63,120
$120.49 P/Share
|
|
Mar 07
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-1.68%
|
$60,720
$120.49 P/Share
|
|
Mar 07
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
512
-0.74%
|
$61,440
$120.49 P/Share
|
|
Mar 07
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-1.93%
|
$60,720
$120.49 P/Share
|
|
Mar 05
2024
|
Stephen Mayo |
SELL
Open market or private sale
|
Direct |
3,135
-32.13%
|
$382,470
$122.96 P/Share
|
|
Mar 04
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,728
-2.43%
|
$216,000
$125.32 P/Share
|
|
Mar 04
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-0.98%
|
$65,250
$125.32 P/Share
|
|
Mar 04
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,734
-5.45%
|
$216,750
$125.32 P/Share
|
|
Mar 04
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,389
-3.55%
|
$173,625
$125.32 P/Share
|
|
Mar 01
2024
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+7.77%
|
-
|
|
Mar 01
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-1.18%
|
$98,028
$126.19 P/Share
|
|
Mar 01
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-5.91%
|
$250,000
$125.34 P/Share
|
|
Mar 01
2024
|
Ryan Edward Brown EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+15.07%
|
-
|
|
Mar 01
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.96%
|
$33,894
$126.19 P/Share
|
|
Mar 01
2024
|
Richard Barry |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+0.06%
|
-
|
|
Mar 01
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,200
-2.98%
|
$153,600
$128.3 P/Share
|
|
Mar 01
2024
|
Ian Michael Estepan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+12.96%
|
-
|
|
Mar 01
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.05%
|
$45,990
$126.19 P/Share
|